Calcium Channel Blocker (CCB) Overdose — Emergency Management

Pathophysiology

• Negative chronotropy — SA node suppression → bradycardia
• Negative dromotropy — AV conduction delay → AV block
• Negative inotropy — reduced contractility → cardiogenic shock
• Vasodilation — peripheral vasoplegia → distributive shock

High protein binding and large Vd (>1–2 L/kg) make hemodialysis and hemoperfusion ineffective. — Rosen's Emergency Medicine, p. 2940

Clinical Features

Diagnosis

• ECG (obtain immediately, repeat with any hemodynamic change): look for sinus bradycardia, PR prolongation, AV block, junctional/ventricular escape rhythms
• Glucose (hyperglycemia correlates with severity, indicates HDI)
• Electrolytes — hypokalemia seen in severe overdose; serum Ca usually normal
• Lactate/ABG — lactic acidosis indicates systemic hypoperfusion
• Toxicology screen — CCB levels not routinely available or clinically useful; screen for co-ingestions (especially β-blockers, digoxin)

Treatment Algorithm

Treatment algorithm for severe CCB toxicity — Tintinalli's Emergency Medicine, Fig. 195-1

Step-by-Step Emergency Management

1. Immediate Stabilization

• IV access (large bore), cardiac monitoring, continuous pulse oximetry
• 12-lead ECG, frequent BP measurement
• Secure airway if GCS impaired or hemodynamic collapse imminent

2. GI Decontamination

• Activated charcoal (1 g/kg PO/NG, up to 50 g) if patient presents within 1–2 hours with a protected airway
• Whole bowel irrigation with polyethylene glycol solution should be considered for ER preparations — continue until rectal effluent is clear

3. IV Fluid Resuscitation

• Crystalloids 20 mL/kg IV bolus, may repeat
• Caution: avoid fluid overload (risk of pulmonary edema), especially in elderly or those with cardiac disease

4. Calcium Salts (First-Line Antidote)

• Calcium gluconate 10%: 30 mL IV (3 g) — preferred for peripheral IV access
• Calcium chloride 10%: 10 mL IV (1 g) — more bioavailable calcium, requires central line (risk of tissue necrosis if extravasation)
• May repeat up to 3 times; repeat every 15–20 minutes if needed
• Mechanism: increases extracellular calcium to overcome the blocked channels; transiently reverses hypotension and bradycardia
• Monitor ionized calcium levels if giving repeated doses

5. Atropine (For Bradycardia)

• 0.5 mg IV, up to 3 mg total
• Rarely fully effective; consider a temporizing measure only
• Indicated for HR <50 bpm with hypotension/symptoms

6. Glucagon

• 5 mg IV (may repeat); used mainly for co-ingested β-blocker overdose
• Not routinely recommended in pure CCB overdose — no mechanistic advantage over epinephrine, and no good clinical evidence — Rosen's, p. 2941
• Tintinalli's includes it in the algorithm as a bridging agent if bradycardia persists after calcium

7. High-Dose Insulin (HDI) — Cornerstone of Severe Overdose

8. Vasopressors

• Norepinephrine or epinephrine 1–5 mcg/min IV, titrate to effect
• Start concurrently with HDI (don't wait for HDI to kick in)
• Wean vasopressors first once hemodynamic response is seen

9. Transcutaneous / Transvenous Cardiac Pacing

• For hemodynamically significant bradycardia refractory to medications
• Note: CCB-induced bradycardia often responds poorly to pacing (unlike primary conduction disease)

10. Methylene Blue (Emerging — Vasoplegia)

• 1–2 mg/kg IV as slow infusion
• Inhibits guanylyl cyclase → reduces cGMP → increases SVR
• Particularly useful for vasoplegia unresponsive to maximum doses of norepinephrine and vasopressin
• A reasonable option when conventional vasopressors are maxed — Rosen's, p. 2941

11. Intravenous Lipid Emulsion (ILE / Intralipid)

• 20% lipid emulsion: 1.5 mL/kg IV bolus, may repeat; then 0.25 mL/kg/min infusion
• Proposed mechanism: "lipid sink" sequesters lipophilic CCB molecules
• Reserve for refractory cardiogenic shock not responding to IV fluids, calcium, HDI, and ≥3 vasopressors at max doses, AND when ECMO is not immediately available
• Evidence is limited; large follow-up studies showed poor outcomes in humans

12. ECMO (Extracorporeal Membrane Oxygenation)

• Preferred salvage therapy over lipid emulsion when available
• Indicated for patients in refractory cardiogenic arrest or shock despite all above measures
• A 2024 systematic review (PMID 38165982) confirms a role for ECMO in severe CCB overdose
• If at a non-ECMO facility, arrange urgent transfer; consider ILE as bridge

Summary — Escalation Ladder

IV Fluids + Calcium salts
         ↓ (if inadequate)
HDI + Vasopressors (concurrent)
         ↓ (if refractory)
Atropine ± Pacing | Glucagon (β-blocker co-ingestion)
         ↓ (if refractory)
Methylene blue (vasoplegia)
         ↓ (if cardiogenic shock persists)
ILE (if no ECMO) OR ECMO (preferred)

Special Considerations